Meredith IT, Verheye S, Dubois CL, Dens J, Fajadet J, Carrié D, et al. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. J Am Coll Cardiol. 2012;59(15):1362–70.
Article
Google Scholar
Harmouche M, Maasrani M, Verhoye J-P, Corbineau H, Drochon A. Coronary three-vessel disease with occlusion of the right coronary artery: what are the most important factors that determine the right territory perfusion? IRBM. 2014;35(3):149–57.
Article
Google Scholar
Eltchaninoff H, Koning R, Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol. 1998;32(4):980–4.
Article
Google Scholar
Giacoppo D, Colleran R, Cassese S, Frangieh AH, Wiebe J, Joner M, et al. Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis. JAMA Cardiol. 2017;2(10):1079–88.
Article
Google Scholar
Iqbal J, Gunn J, Serruys PW. Coronary stents: historical development, current status and future directions. Br Med Bull. 2013;106(1):193–211.
Article
Google Scholar
Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773–80.
Article
Google Scholar
Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150.
Article
Google Scholar
Pilgrim T, Windecker S. Antiplatelet therapy for secondary prevention of coronary artery disease. Heart. 2014;100(22):1750–6.
Article
Google Scholar
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–23.
Article
Google Scholar
Sehgal SN. Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem. 1998;31(5):335–40.
Article
MathSciNet
Google Scholar
Marx SO, Marks AR. Bench to bedside. Circulation. 2001;104(8):852–5.
Article
Google Scholar
Cremers B, Toner JL, Schwartz LB, von Oepen R, Speck U, Kaufels N, et al. Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol. 2012;101(6):469–76.
Article
Google Scholar
Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, et al. Polymer-free Biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Circul Cardiovasc Interven. 2010;3(2):174–83.
Article
Google Scholar
Patterson C, Mapera S, Li H-H, Madamanchi N, Hilliard E, Lineberger R, et al. Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival. Arterioscler Thromb Vasc Biol. 2006;26(7):1473–80.
Article
Google Scholar
Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–31.
Article
Google Scholar
Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim D-W, Ware M, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 2001;103(18):2289–95.
Article
Google Scholar
McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. The Lancet. 2004;364(9444):1519–21.
Article
Google Scholar
Forrestal B, Lipinski M. Bioresorbable scaffolds: fading away or hope for the future. J Am Coll Cardiol 2018;7.
Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, et al. 3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial. J Am Coll Cardiol. 2017;70(23):2852–62.
Article
Google Scholar
Watson T, Webster MWI, Ormiston JA, Ruygrok PN, Stewart JT. Long and short of optimal stent design. Open Heart. 2017;4(2):e000680.
Article
Google Scholar
Haude M, Ince H, Kische S, Toelg R, Van Mieghem NM, Verheye S, et al. Sustained safety and performance of the second-generation sirolimus-eluting absorbable metal scaffold: pooled outcomes of the BIOSOLVE-II and-III trials at 3 years. Cardiovasc Revasc Med. 2020;21(9):1150–4.
Article
Google Scholar
Lee M, Wlodarczak A, Bennett J, Torzewski J, Haude M, Vrolix M, et al. TCT-350 safety and performance of the resorbable magnesium scaffold, magmaris in a real world setting-first 400 subjects at 12-month follow-up of the BIOSOLVE-IV registry. J Am Coll Cardiol. 2018;72(13S):B142–3.
Article
Google Scholar
Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, et al. Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention. Circul Cardiovasc Interven. 2016;9(7):e003610.
Google Scholar
Chevalier B, Smits PC, Carrié D, Mehilli J, Boven AJV, Regar E, et al. Serial Assessment of strut coverage of biodegradable polymer drug-eluting stent at 1, 2, and 3 months after stent implantation by optical frequency domain imaging. Circul Cardiovasc Interven. 2017;10(12):e004801.
Google Scholar
Cuculi F, Puricel S, Jamshidi P, Valentin J, Kallinikou Z, Toggweiler S, et al. Optical coherence tomography findings in bioresorbable vascular scaffolds thrombosis. Circul Cardiovasc Interven. 2015;8(10):e002518.
Google Scholar
Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC. Pathological correlates of late drug-eluting stent thrombosis. Circulation. 2007;115:2435–41.
Article
Google Scholar
Gori T, Jansen T, Weissner M, Foin N, Wenzel P, Schulz E, et al. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms. Eur Heart J. 2015;37(26):2040–9.
Article
Google Scholar
Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H, et al. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer. Circul Cardiovasc Interven. 2010;3(4):367–75.
Article
Google Scholar
Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction. Circulation. 2011;123(3):274–81.
Article
Google Scholar
Guagliumi G, Bezerra HG, Sirbu V, Ikejima H, Musumeci G, Biondi-Zoccai G, et al. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circul Cardiovasc Interven. 2012;5(1):30–8.
Article
Google Scholar
Jaguszewski M, Dörig M, Frangieh AH, Ghadri J-R, Cammann VL, Diekmann J, et al. Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome. Catheter Cardiovasc Interv. 2016;88(6):E173–82.
Article
Google Scholar
Kaiser C, Galatius S, Jeger R, Gilgen N, Jensen JS, Naber C, et al. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents. Circulation. 2015;131(1):74–81.
Article
Google Scholar
Kandzari DE, Smits PC, Love MP, Ben-Yehuda O, Banai S, Robinson SD, et al. Randomized comparison of ridaforolimus- and zotarolimus-eluting coronary stents in patients with coronary artery disease. Circulation. 2017;136(14):1304–14.
Article
Google Scholar
Kereiakes DJ, Meredith IT, Windecker S, Jobe RL, Mehta SR, Sarembock IJ, et al. Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. Circul Cardiovasc Interven. 2015;8(4):e002372.
Google Scholar
Nakano M, Otsuka F, Yahagi K, Sakakura K, Kutys R, Ladich ER, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013;34(42):3304–13.
Article
Google Scholar
Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010;31(12):1470–6.
Article
Google Scholar
Pache J, Dibra A, Mehilli J, Dirschinger J, Schömig A, Kastrati A. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J. 2005;26(13):1262–8.
Article
Google Scholar
Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis. J Am Coll Cardiol. 2011;58(15):1578–88.
Article
Google Scholar
Silenzi S, Grossi P, Mariani L, Fraccaro C, Vagnarelli F, Moretti L. Effect on clinical restenosis of an ultra-thin-strut bare metal cobalt-chromium stent versus a thin-strut stainless steel stent. J Interv Cardiol. 2016;29(3):300–10.
Article
Google Scholar
Wessely R, Kastrati A, Mehilli J, Dibra A, Pache J, Schömig A. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. Eur Heart J. 2007;28(22):2720–5.
Article
Google Scholar
Velut J, Lentz P-A, Boulmier D, Coatrieux J-L, Toumoulin C. Assessment of qualitative and quantitative features in coronary artery MRA. IRBM. 2011;32(4):229–42.
Article
Google Scholar
Feuillâtre H, Sanokho B, Nunes J-C, Bedossa M, Toumoulin C. Automatic determination of optimal view for the visualization of coronary lesions by rotational X-ray angiography. IRBM. 2013;34(4–5):291–5.
Article
Google Scholar
Li H, Liu T, Wang M, Zhao D, Qiao A, Wang X, et al. Design optimization of stent and its dilatation balloon using kriging surrogate model. Biomed Eng Online. 2017;16(1):13.
Article
Google Scholar
Li H, Gu J, Wang M, Zhao D, Li Z, Qiao A, et al. Multi-objective optimization of coronary stent using Kriging surrogate model. Biomed Eng Online. 2016;15(2):148.
Article
Google Scholar
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0: The Cochrane Collaboration. 2011.
Geraci S, La Manna A, Tamburino C. Optical coherence tomography for coronary imaging. J Cardiol Pract. 2010;9:12.
Google Scholar
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Es G-A, et al. Clinical end points in coronary stent trials. Circulation. 2007;115(17):2344–51.
Article
Google Scholar
Mabrouk S, Oueslati C, Ghorbel F. Multiscale graph cuts based method for coronary artery segmentation in angiograms. IRBM. 2017;38(3):167–75.
Article
Google Scholar
Kouvahe AF, Fetita C. A generic approach for efficient detection of vascular structures. IRBM. 2020;41(6):304–15.
Article
Google Scholar
Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, et al. Population trends in percutaneous coronary intervention. J Am Coll Cardiol. 2013;61(12):1222–30.
Article
Google Scholar
Zacca-González G, Chinchilla-Rodríguez Z, Vargas-Quesada B, de Moya-Anegón F. Bibliometric analysis of regional Latin America’s scientific output in public health through SCImago journal & country rank. BMC Public Health. 2014;14(1):1–11.
Article
Google Scholar
Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31(1):224–30.
Article
Google Scholar
Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105(25):2974–80.
Article
Google Scholar
Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99(1):44–52.
Article
Google Scholar
Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schühlen H, Neumann F-J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001;103(23):2816–21.
Article
Google Scholar
Pache J, Kastrati A, Mehilli J, Schühlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41(8):1283–8.
Article
Google Scholar
Rittersma SZ, de Winter RJ, Koch KT, Bax M, Schotborgh CE, Mulder KJ, et al. Impact of strut thickness on late luminal loss after coronary artery stent placement. Am J Cardiol. 2004;93(4):477–80.
Article
Google Scholar
Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns R-JM, et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J. 2010;31(2):165–76.
Article
Google Scholar
Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Belle EV, et al. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial. J Am Coll Cardiol. 2012;59(25):2327–37.
Article
Google Scholar
Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017;38(42):3139–47.
Article
Google Scholar
Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27(7):1500–10.
Article
Google Scholar
Eppihimer MJ, Sushkova N, Grimsby JL, Efimova N, Kai W, Larson S, et al. Impact of stent surface on thrombogenicity and vascular healing. Circul Cardiovasc Interven. 2013;6(4):370–7.
Article
Google Scholar
Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–34.
Article
Google Scholar
Vorpahl M, Finn AV, Nakano M, Virmani R. The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention. 2009;5:F28–35.
Article
Google Scholar
Onuma Y, Serruys PW, Perkins LEL, Okamura T, Gonzalo N, García-García HM, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model. Circulation. 2010;122(22):2288–300.
Article
Google Scholar
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol. 2006;48(1):193–202.
Article
Google Scholar
Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 2009;57(5):567–84.
Google Scholar
Ellis SG, Kereiakes DJ, Stone GW, editors. Everolimus-eluting bioresorbable vascular scaffolds in patients with coronary artery disease: ABSORB III trial 2-year results. In: Annual Meeting of the American College of Cardiology; 2017.
Sojitra P, Engineer C, Kothwala D, Raval A, Kotadia H, Mehta G. Electropolishing of 316LVM stainless steel cardiovascular stents: an investigation of material removal, surface roughness and corrosion behaviour. Artif Organs. 2010;23(3):115–21.
Google Scholar
Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89(6):651–6.
Article
Google Scholar
Stone GW, Ellis SG, Gori T, Metzger DC, Stein B, Erickson M, et al. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial. The Lancet. 2018;392(10157):1530–40.
Article
Google Scholar